-
French readers lap up Sarkozy's prison diaries
-
UK PM warns Abramovich 'clock is ticking' over Chelsea sale fund
-
Warner Bros. Discovery rejects Paramount bid
-
Winners of 2026 World Cup to pocket $50 million in prize money
-
World no. 1 Alcaraz ends 'incredible ride' with coach Ferrero
-
World number one Alcaraz announces 'difficult' split with coach Ferrero
-
Iran boxer sentenced to death at 'imminent' risk of execution: rights groups
-
Snicko operator admits error that led to Carey's Ashes reprieve
-
Finland PM apologises to Asian countries over MPs' mocking posts
-
Doctors in England go on strike for 14th time
-
Romania journalists back media outlet that sparked graft protests
-
Rob Reiner's son awaiting court appearance on murder charges
-
Ghana's Highlife finds its rhythm on UNESCO world stage
-
Stocks gain as traders bet on interest rate moves
-
France probes 'foreign interference' after malware found on ferry
-
Europe's Ariane 6 rocket puts EU navigation satellites in orbit
-
Bleak end to the year as German business morale drops
-
Hundreds queue at Louvre museum as strike vote delays opening
-
Bondi shooting shocks, angers Australia's Jewish community
-
Markets rise even as US jobs data fail to boost rate cut bets
-
Senegal talisman Mane overcame grief to become an African icon
-
Carey pays tribute to late father after home Ashes century
-
'Many lessons to be learned' from Winter Games preparations, says ski chief
-
Emotional Carey slams ton to give Australia upper hand in 3rd Ashes Test
-
Asian markets mixed as US jobs data fails to boost rate cut hopes
-
Carey slams ton as Australia seize upper hand in third Ashes Test
-
Bondi shooting shocks, angers Australia Jewish community
-
Myanmar junta seeks to prosecute hundreds for election 'disruption'
-
West Indies hope Christmas comes early in must-win New Zealand Test
-
Knicks beat Spurs in NBA Cup final to end 52-year trophy drought
-
Khawaja revels in late lifeline as Australia 194-5 in 3rd Ashes Test
-
Grief and fear as Sydney's Jewish community mourns 'Bondi rabbi'
-
Trump orders blockade of 'sanctioned' Venezuela oil tankers
-
Brazil Senate to debate bill to slash Bolsonaro jail term
-
New Zealand ex-top cop avoids jail time for child abuse, bestiality offences
-
Eurovision facing fractious 2026 as unity unravels
-
'Extremely exciting': the ice cores that could help save glaciers
-
Asian markets drift as US jobs data fails to boost rate cut hopes
-
What we know about Trump's $10 billion BBC lawsuit
-
Ukraine's lost generation caught in 'eternal lockdown'
-
'Catastrophic mismatch': Safety fears as Jake Paul faces Anthony Joshua
-
Australia's Steve Smith ruled out of third Ashes Test
-
Khawaja grabs lifeline as Australia reach 94-2 in 3rd Ashes Test
-
Undefeated boxing great Crawford announces retirement
-
Trump says orders blockade of 'sanctioned' Venezuela oil tankers
-
UK experiences sunniest year on record
-
Australia holds first funeral for Bondi Beach attack victims
-
FIFA announces $60 World Cup tickets after pricing backlash
-
Maresca relishes support of Chelsea fans after difficult week
-
Medical Care Technologies, Inc. (OTC Pink:MDCE) Announces Completion of AI-Based Consumer App, Now in iOS App Store Review
SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses
AUSTIN, TX / ACCESS Newswire / April 19, 2025 / Software Effective Solutions Corp. (OTC:SFWJ), doing business as Medcana, today announced it is proceeding with the acquisition of pharmaceutical cannabis licenses to import and distribute cannabis in Australia.
This move marks a significant milestone in Medcana's global growth strategy. By entering the Australian market, Medcana further strengthens its international footprint in the medical cannabis industry and enhances its global capabilities in both production and distribution of pharmaceutical-grade cannabis products.
The acquired licenses will allow Medcana to import high-quality, research-driven cannabis products into Australia and establish distribution partnerships to meet the growing demand for medical cannabis in the region.
José Gabriel Díaz, CEO of Medcana, commented:
"This is a pivotal step forward for Medcana. Expanding into Australia is not only a strategic decision-it solidifies our position as a global player in the medical cannabis sector. With operations now reaching into Latin America and the Asia-Pacific region, we're uniquely positioned to lead the international supply chain for pharmaceutical cannabis."
About Medcana
Medcana is a U.S.-based public company operating in the international medical cannabis sector. Through its Colombian operations and strategic partnerships, Medcana is focused on the production, research, and global distribution of high-quality pharmaceutical-grade cannabis products.
For investor relations or media inquiries, please contact:
[email protected]
http://www.medcana.co/
Twitter: @MedcanaCo
SOURCE: Software Effective Solutions
View the original press release on ACCESS Newswire
P.A.Mendoza--AT